Liu Doctor Chief Physician

Peking University Third Hospital · Department of Endocrinology · Chief Physician

This physician graduated from Peking University Health Science Center in 2011 and currently serves as Associate Chief Physician in Endocrinology at Peking University Third Hospital, with training at Harvard's Joslin Diabetes Center. Research focuses on diabetes, endocrine metabolism, and reproductive health, leading National Natural Science Foundation and other major projects. Recognized with multiple awards, including Outstanding Young Physician and Beijing Municipal Science and Technology Awar

Diabetes, endocrine disorders, and reproductive health

Liu Doctor
Basic Information

About Dr. Liu Doctor

Hospital
Peking University Third Hospital
Title
Chief Physician
Department
Department of Endocrinology
Years of Practice
28 years (1998 — present)
Work Experience In 2011, I graduated from Peking University Health Science Center with a Doctor of Medicine degree in Clinical Medicine. Following graduation, I remained at the university and have been working in the Department of Endocrinology at Peking University Third Hospital ever since, successively holding the positions of Resident Physician, Attending Physician, and Associate Chief Physician. I also completed a short-term study program at the Joslin Diabetes Center at Harvard University in the United States. Research Work Main Research Interests: Basic and clinical research on diabetes, endocrine metabolism and reproductive health. I have led projects funded by the National Natural Science Foundation of China, the Beijing Municipal Natural Science Foundation, the Doctoral Program Teachers' Fund of the Ministry of Education, and key clinical projects at Peking University Third Hospital, and have participated in multiple other national and provincial/ministerial level research projects. Awards and Honors Outstanding Young Physician of Peking University Third Hospital Young Academic Leader of Peking University Third Hospital 2020, Outstanding Communist Party Member of Peking University 2016, Beijing Municipal Science and Technology Award, Third Prize (5/6) 2016, Outstanding Resident Physician of Beijing Publications As first author (including co-first author) or corresponding author, I have published over 20 papers in Chinese and English journals, some of which are listed below: 1. Ye Liu, Ran Lu, Junhong Wang, Qin Cheng, Ruitao Zhang, Shuisheng Zhang, Yunyi Le, Haining Wang, Wenhua Xiao, Hongwei Gao, Lin Zeng, Tianpei Hong*. Diabetes, even newly defined by HbA1c testing, is associated with an increased risk of in-hospital death in adults with COVID-19. BMC Endocr Disord. 2021; 21(1):56. 2. Ye Liu, Qin Cheng, Junhong Wang, Shu Li, Ci Tian, Yuxuan Li, Wenhui Zhang, Ning Shen, Jie Qiao*. Family companion between patients with coronavirus disease 2019: a retrospective observational study. Chin Med J (Engl). 2020, 133(20):2507-2509. 3. Wang H, Liu Y (Co-first author), Tian Q, Yang J, Lu R, Zhan S, Haukka J, Hong T*. Incretin-based therapies and risk of pancreatic cancer in patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2018, 20(4):910-920. 4. Liu Y, Tian Q, Yang J, Wang H, Hong T*. No pancreatic safety concern following glucagon-like peptide-1 receptor agonist therapies: A pooled analysis of cardiovascular outcome trials. Diabetes Metab Res Rev. 2018, 34(8):e3061. 5. Liu Y, Hong T*. Combination therapy of dipeptidyl peptidase-4 inhibitors and metformin in type 2 diabetes: rationale and evidence. Diabetes Obes Metab, 2014, 16(2):111-117. 6. Wang L, Liu Y (Co-first author), Yang J, Zhao HJ, Ke J, Tian Q, Zhang L, Wen JH, Wei R*, Hong TP*. Liraglutide upregulates PC1-mediated Proinsulin processing in pancreatic cells via a PKA-dependent pathway. Endocrinology. 2014, 155(10):3817-3828. 7. Liu Y, Rui Wei, Tianpei Hong*. Potential Roles and Mechanisms of Glucagon-like Peptide-1 in Non-alcoholic Fatty Liver Disease. World J Gastroenterol. 2014, 20(27): 9090-9097. 8. Wei Ying, Liu Ye*, Wang Haining. Research progress on the effects of hyperandrogenemia during pregnancy on offspring glucose metabolism. National Medical Journal of China, 2022, 102(6): 445-448. 9. Liu Ye, Wang Haining, Wei Yuan, Xue Yanmei, Gao Hongwei, Hong Tianpei*. A prospective cohort study on factors associated with postpartum glucose metabolism outcomes in women with gestational diabetes mellitus. Chinese Journal of Diabetes Mellitus, 2020, 12(10): 814-818. DOI: 10.3760/cma.j.cn115791-20200120-00029 10. Liu Ye, Hong Tianpei*, Wei Rui, Yang Jin. Glucagon-like peptide 1: a new therapeutic target for non-alcoholic fatty liver disease? Chinese Journal of Endocrinology and Metabolism, 31(5): 386-389, 2015. 11. Liu Ye, Hong Tianpei*. Pathophysiological basis and management strategies for the comorbidity of non-alcoholic fatty liver disease and type 2 diabetes mellitus. National Medical Journal of China, 95(44): 3565-3567, 2015. Books and Translations Co-editor of "The Complete Guide to Coping with Diabetes" and "Know About Thyroid Issues Early"
Schedule

Dr. Liu Doctor — Outpatient Schedule

Weekly clinic, including specialist and surgery days. Book 3-7 days in advance.

Clinic: Peking University Third Hospital · Department of Endocrinology
On Duty
Off Duty
Period Morning
08:00-12:00
Afternoon
14:00-17:30
Evening
18:30-20:30
Mon Off Duty Off Duty Off Duty
Tue
08:00 - 12:00
Off Duty Off Duty
Wed Off Duty Off Duty Off Duty
Thu Off Duty Off Duty Off Duty
Fri Off Duty Off Duty Off Duty
Sat Off Duty Off Duty Off Duty
Sun Off Duty Off Duty Off Duty
Note: Actual clinic hours are subject to the hospital's daily notice. Please call the Dovecure 24h hotline 400-888-0000 to confirm before booking.

Rationale for Precision

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

Book your dedicated advisor now

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

Consult Now
24/7 medical consultation +86 18126771334 (iMessage)
Email Consultation cure@dovecure.com
WhatsApp WeChat QR Code WeChat QR Code
Cart
Your cart is empty
Continue shopping
{{ item.sku_code }} - {{ item.variant_label }} {{ item.item_type_label }}
{{ item.price_format }}
{{ item.subtotal_format }}
Total {{ totalAmount }}
Checkout View Cart
Consult